–News Direct– Trident Royalties PLC (AIM:TRR, OTCQX:TDTRF) CEO Adam Davidson joined Proactive's Stephen Gunnion with details of the company's performance for the quarter ended 31 March 2024. Royalty income approached amounted to US$2.98 million, with a notable performance from its gold offtake portfolio, especially during March which continued into the second quarter due to favourable […]

–News Direct– Aclara Resources Inc (TSX:ARA, OTC:ARAAF) chief operating officer Barry Murphy joined Proactive's Stephen Gunnion with news that the company has contracted global multidisciplinary consultancy firm Hatch to complete the prefeasibility study (PFS) for the Carina Module rare earths project in Brazil. Murphy cited Hatch's extensive experience and good fit with Aclara's team as […]

–News Direct– By Austin DeNoce, Benzinga The cryptocurrency market has been a rollercoaster of innovation and growth, but it's not without its share of pitfalls. National Futures Association (NFA), the self-regulatory organization for the U.S. derivatives industry, does not have regulatory oversight of the spot virtual currency. This lack of regulation for many crypto exchanges […]

–News Direct– RC365 Holding PLC (LSE:RCGH) has made significant progress in 2024, according to CEO Michael Law, in an interview with Proactive's Stephen Gunnion. The company has transitioned 100% of its office operations, including finance, IT, and customer service, to Malaysia and Indonesia, hiring over ten new staff members in the region. RC365 has also […]

–News Direct– Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) chief legal officer John McEvoy joins Proactive's Stephen Gunnion with news that POLB 001's Immuno-modulator II has received the fully granted patent from the US Patent Office. McEvoy explained the patent encompasses a class of drugs for treating and preventing hypercytokinemia (cytokine storms) in patients triggered by an […]

–News Direct– Faron Pharmaceuticals Limited (AIM:FARN) new CEO Dr Juho Jalkanen joined Proactive's Stephen Gunnion with his vision for the company. The founding member and former chief operating officer of Faron said one of his priorities is to meet with the US Food & Drug Administration earlier than planned in the hope of fast-tracking its […]

–News Direct– Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Dr Tom Becker takes Proactive's Stephen Gunnion through the company's 2023 full-year performance, which marked another record. Iofina achieved its first-ever revenue exceeding $50 million, marking the sixth consecutive year of growth, a roughly 18% increase from the previous year, with EBITDA at $10.8 million. Becker attributed the […]

–News Direct– Electric Guitar PLC (AIM:ELEG) CEO John Regan spoke to Proactive's Stephen Gunnion following the company's listing on London's AIM market following the reverse takeover of 3radical. Regan emphasized Electric Guitar's "buy and build" strategy, which involves acquiring complementary businesses to enhance their market position. Despite the challenging market conditions, the company managed to […]

–News Direct– ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with details of a supplier agreement with AstraZeneca PLC to develop an androgen receptor (AR) detection assay to enhance prostate cancer studies. With a contract value of 550,000, the project is scheduled for completion in the first quarter of next year. Newland said […]

–News Direct– HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) president and CEO Aydin Kilic joined Stephen Gunnion in Proactive's London studio with insights into the companys transition and growth. Initially established as the first publicly traded crypto mining company in 2017, HIVE began by mining Ethereum in Iceland before expanding to Sweden and Canada. Following Ethereum's transition […]